Adeona, Meda deal

Adeona granted Meda exclusive rights to develop and commercialize flupirtine to treat fibromyalgia in the U.S., Canada and Japan, including an issued U.S. patent

Read the full 242 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE